Riskpilot← Back to searchSign inGet full accessMEDU NORGE AS
ASActiveOrg 978707629Snarøyveien 36, 1364 FornebuWholesale of pharmaceutical and medical goods · NACE 4646Est. 199716 employeeswww.avalon-medical.no
Revenue 2024
NOK 76M
+32% vs 2023
EBITDA margin
-1.5%
+79% vs 2023
Equity ratio
18.0%
Financial strength
Net profit 2024
NOK -2,1M
+62% vs 2023
| Revenue | NOK 76M | +32% |
| EBITDA | NOK -1,2M | +79% |
| Net profit | NOK -2,1M | +62% |
| Total assets | NOK 38,5M | +4% |
| Equity | NOK 6,9M | -15% |
| Employees | 16 | — |
Legal name
MEDU NORGE AS
Org number
978707629
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. juli 1997
Share capital
NOK 732 000
Employees
16 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Address
Snarøyveien 36, 1364 Fornebu
Website
www.avalon-medical.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 53 452 | 44 630 | 51 853 | 57 405 | 75 955 |
| Staff expenses | −8 556 | −9 318 | −12 915 | −13 691 | −14 591 |
| EBITDA | 179 | 2 994 | −1 637 | −5 541 | −1 158 |
| Depreciation & amort. | −183 | −686 | −385 | −891 | −1 078 |
| EBIT | −4 | 2 308 | −2 023 | −6 432 | −2 235 |
| Net financials | −618 | −103 | −179 | −723 | −1 039 |
| Profit before tax | −622 | 2 205 | −2 202 | −7 155 | −3 274 |
| Tax | −134 | 496 | −474 | −1 567 | −1 174 |
| Net profit | −488 | 1 710 | −1 727 | −5 588 | −2 100 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 18 867 | 28 460 | 27 933 | 36 819 | 38 461 |
| Equity | 13 255 | 15 461 | 13 734 | 8 146 | 6 936 |
| Long-term debt | 0 | 5 024 | 2 758 | 10 412 | 13 560 |
| Short-term debt | 5 611 | 7 975 | 11 241 | 18 061 | 17 765 |
| Total debt | 5 611 | 12 999 | 13 999 | 28 473 | 31 325 |
EBITDA margin
-1.5%
This company
15.8%
Market median
-109% vs market
20202024
Equity ratio
18.0%
This company
38.2%
Market median
-53% vs market
20202024
Return on equity
-30.3%
This company
18.4%
Market median
-265% vs market
20202024
Net profit margin
-2.8%
This company
8.1%
Market median
-135% vs market
20202024
Asset turnover
1.97×
This company
1.12×
Market median
+76% vs market
20202024
Debt / equity
4.55×
This company
0.62×
Market median
-634% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MK Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (1) | ||
SA Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2026 | |
| Former (3) | ||
| Board of Directors | 2022 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Chairman | 2022 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Medu Holding As
MEDU NORGE AS Board members of MEDU NORGE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sturle Andre Ramvik Grønbeck | Chief Executive Officer | 0 companies |
| May Kristin Svenkerud | Chief Executive Officer | 0 companies |
| Christopher Segtnan Tangen | Board of Directors | 0 companies |
| Magne Stoknes | Board of Directors | 0 companies |
| Torkild Stenbock | Chairman | 0 companies |
| Anders Rabben Kjøde | Board of Directors | 0 companies |
| Synne Hermansen Røine | Chairman | 0 companies |
| Trond Dahl Hansen | Chairman | 0 companies |